Edinburgh Research Explorer

Prof Alistair Williams

(Former employee or visitor)

  1. 2019
  2. High EMSY expression defines a BRCA-like subgroup of high grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

    Hollis, R., Churchman, M., Michie, C. O., Rye, T., Knight, L., McCavigan, A., Perren, T., Williams, A., McCluggage, G. W., Kaplan, R. S., Jayson, G. C., Oza, A., Harkin, P. D., Herrington, C., Kennedy, R. & Gourley, C., 2 Jun 2019, In : Cancer.

    Research output: Contribution to journalArticle

  3. Safety and Efficacy of the Selective Progesterone Receptor Modulator Asoprisnil for Heavy Menstrual Bleeding With Uterine Fibroids: Pooled Analysis of Two 12-Month, Placebo-Controlled, Randomized Trials

    Stewart, E. A., Diamond, M. P., Williams, A., Carr, B. R., Myers, R. E., Feldman, R., Elger, W., Mattia-Goldberg, C., Schwefel, B. M. & Chwalisz, K., 13 Feb 2019, In : Human Reproduction. p. 1-12

    Research output: Contribution to journalArticle

  4. Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease

    Pan, J., Kavanagh, K., Cuschieri, K., Pollock, K. G. J., Gilbert, D. C., Bell, S., Graham, S. V., Williams, A., Cruickshank, M. E., Palmer, T. & Wakeham, K., 16 Jan 2019, In : International Journal of Cancer.

    Research output: Contribution to journalArticle

  5. 2018
  6. Development of an in-house ELISA to detect anti-HPV16-L1 antibodies in serum and dried blood spots

    Bhatia, R., Stewart, J., Moncur, S., Cubie, H., Kavanagh, K., Pollock, K. G. J., Busby-Earle, C., Williams, A. R. W., Howie, S. & Cuschieri, K., 22 Oct 2018, In : Journal of Virological Methods. 264, p. 55-60 6 p.

    Research output: Contribution to journalArticle

  7. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

    Xintaropoulou, C., Ward, C., Wise, A., Queckborner, S., Turnbull, A., Michie, C. O., Williams, A., Rye, T., Gourley, C. & Langdon, S., 5 Jun 2018, In : BMC Cancer.

    Research output: Contribution to journalArticle

  8. Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions

    Bhatia, R., Kavanagh, K., Stewart, J., Moncur, S., Serrano, I., Cong, D., Cubie, H., Haas, J., Busby-Earle, C., Williams, A., Howie, S. & Cuschieri, K., 6 Apr 2018, In : Oncotarget. 9, p. 18548-18558

    Research output: Contribution to journalArticle

  9. 2017
  10. Characterization of molecular changes in endometrium associated with chronic use of progesterone receptor modulators: ulipristal acetate vs. mifepristone

    Kannan, A., Bhurke, A., Sitruk-Ware, R., G. Lalitkumar, P., Gemzell-danielsson, K., Williams, A., Taylor, R. N., Bagchi, M. K. & Bagchi, I. C., 14 Dec 2017, In : Reproductive Sciences. p. 1933719117746764

    Research output: Contribution to journalArticle

  11. Uterine fibroids – what’s new?

    Williams, A. R. W., 7 Dec 2017, In : F1000Research. 6, p. 2109

    Research output: Contribution to journalArticle

  12. Abstract MIP-055: IDENTIFICATION OF A MOLECULAR SUBTYPE OF HIGH GRADE SEROUS OVARIAN CANCER REPRESENTING MAPK PATHWAY ACTIVATION AND PLATINUM RESISTANCE

    El-helali, A., Mccabe, N., Gourley, C., Mccavigan, A., Michie, C. O., Price, B., Mcgivern, N., Churchman, M., El-helai, A., O'brien, E. J., Hill, L., Davison, T. S., Williams, A., Mccluggage, W. G., Keating, K. E., Harkin, D. P. & Kennedy, R., 31 May 2017, p. MIP-055-MIP-055.

    Research output: Contribution to conferenceOther

  13. Safety after extended repeated use of ulipristal acetate for uterine fibroids

    Fauser, B. C. J. M., Donnez, J., Bouchard, P., Barlow, D. H., Vázquez, F., Arriagada, P., Skouby, S. O., Palacios, S., Tomaszewski, J., Lemieszczuk, B. & Williams, A., 7 Mar 2017, In : PLoS ONE. 12, 3, p. e0173523

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...11 Next